Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1817769-42-8
2. Mxd6kmg2zp
3. Refchem:1099421
4. Tegomil Fumurate
5. Fumurate De Tegomil
6. Fumurato De Tegomil
7. Tegomil Fumarate [inn]
8. Orb1943741
9. Chembl5314544
10. Schembl17187305
11. Da-68022
12. Hy-156645
13. Cs-0887138
14. 1,21-dimethyl (2e,19e)-4,18-dioxo-5,8,11,14,17-pentaoxaheneicosa-2,19-dienedioate
15. 5,8,11,14,17-pentaoxaheneicosa-2,19-dienedioic Acid, 4,18-dioxo-, 1,21-dimethyl Ester, (2e,19e)-
| Molecular Weight | 418.4 g/mol |
|---|---|
| Molecular Formula | C18H26O11 |
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 20 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 133 |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 506 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
L - Antineoplastic and immunomodulating agents
L04 - Immunosuppressants
L04A - Immunosuppressants
L04AX - Other immunosuppressants
L04AX10 - Tegomil fumarate
ATCvet Code
QL - Antineoplastic and immunomodulating agents
QL04 - Immunosuppressants
QL04A - Immunosuppressants
QL04AX - Other immunosuppressants
QL04AX10 - Tegomil fumarate
Drugs in Development
Details:
Tegomil Fumarate is a small molecule drug candidate, which is currently being evaluated in Approved FDF clinical studies for the treatment of Multiple Sclerosis, Relapsing-Remitting.
Lead Product(s): Tegomil fumarate,Inapplicable
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 02, 2025
Lead Product(s) : Tegomil fumarate,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Neuraxpharm strengthens multiple sclerosis portfolio with the launch of Riulvy® (tegomil fumarate...
Details : Tegomil Fumarate is a small molecule drug candidate, which is currently being evaluated in Approved FDF clinical studies for the treatment of Multiple Sclerosis, Relapsing-Remitting.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 02, 2025
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Riulvy
Dosage Form : Gastro-Resistant Hard Capsule
Dosage Strength : 174MG
Packaging :
Approval Date : 05-09-2025
Application Number : 1251947002
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Riulvy
Dosage Form : Gastro-Resistant Hard Capsule
Dosage Strength : 348MG
Packaging :
Approval Date : 05-09-2025
Application Number : 1251947004
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Riulvy
Dosage Form : Enteric-Coated Capsule
Dosage Strength : 174mg
Packaging :
Approval Date : 29-07-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Riulvy
Dosage Form : Enteric-Coated Capsule
Dosage Strength : 348mg
Packaging :
Approval Date : 29-07-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
ABOUT THIS PAGE
11
PharmaCompass offers a list of Tegomil fumarate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Tegomil fumarate manufacturer or Tegomil fumarate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tegomil fumarate manufacturer or Tegomil fumarate supplier.
A Tegomil fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tegomil fumarate, including repackagers and relabelers. The FDA regulates Tegomil fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tegomil fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tegomil fumarate supplier is an individual or a company that provides Tegomil fumarate active pharmaceutical ingredient (API) or Tegomil fumarate finished formulations upon request. The Tegomil fumarate suppliers may include Tegomil fumarate API manufacturers, exporters, distributors and traders.
Tegomil fumarate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tegomil fumarate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Tegomil fumarate GMP manufacturer or Tegomil fumarate GMP API supplier for your needs.
A Tegomil fumarate CoA (Certificate of Analysis) is a formal document that attests to Tegomil fumarate's compliance with Tegomil fumarate specifications and serves as a tool for batch-level quality control.
Tegomil fumarate CoA mostly includes findings from lab analyses of a specific batch. For each Tegomil fumarate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tegomil fumarate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tegomil fumarate EP), Tegomil fumarate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tegomil fumarate USP).
